Notice of Results
8 February 2019
Circassia Pharmaceuticals plc
Notice of Preliminary Results
Circassia Pharmaceuticals plc (LSE: CIR) will announce its preliminary results for the year ended 31 December 2018 on Wednesday 1 May 2019.
A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am. A webcast of the presentation will be available on the Company's website.
Contacts
Circassia
Steve Harris, Chief Executive Officer Tel: +44 (0) 1865 405 560
Julien Cotta, Chief Financial Officer
Rob Budge, Corporate Communications
Peel Hunt (Nominated Adviser and Joint Broker)
James Steel / Dr Christopher Golden Tel: +44 (0) 20 7418 8900
Numis Securities (Joint Broker)
James Black / Freddie Barnfield Tel: +44 (0) 20 7260 1000
FTI Consulting
Simon Conway / Ciara Martin Tel: +44 (0) 20 3727 1000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Latest directors dealings
- 1 hour ago Johnson Matthey
- 2 hours ago ASOS
- 2 hours ago Coca-Cola Europacific Partners (DI)
- 2 hours ago Liontrust Asset Management
- 2 hours ago Liontrust Asset Management